Moreover, the relationship between TRPML2, TMZ response and resistance mechanisms, and the clinical relevance between the TRPML2 mRNA expression and the OS and PFS in GBM patients will be evaluated. The gene discussed is MCOLN2; the disease is glioblastoma.